Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Kowa identifies aorta-selective ACAT inhibitor acting directly on atherosclerotic process

Dec. 14, 2000

Actelion and Genentech collaborate on development and promotion of Tracleer

Dec. 14, 2000

Start of phase II trial of etomoxir to treat CHF announced

Dec. 14, 2000

Recent data support role for 5-HT2B receptor activation in development of cardiac valvulopathy

Dec. 14, 2000

Cardiovascular agents useful for hypertension and ischemic disorders discovered at CSIR

Dec. 13, 2000

Inhibitors of Lp-PLA2 from SB reportedly useful for atherosclerosis

Dec. 11, 2000

Millennium identifies novel ACE-2 inhibitors for use in cardiovascular disorders

Dec. 7, 2000

Roche/deCODE Genetics alliance identifies genetic risk factor for PAOD

Dec. 7, 2000

Novel Bayer compound stimulates soluble guanylate cyclase

Dec. 5, 2000

Encouraging results reported from early clinical trial of VasoCare for PVD

Dec. 5, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...